The role of tumor associated macrophages (TAMs) in cancer progression, chemoresistance, angiogenesis and metastasis-current status S Dallavalasa, NM Beeraka, CG Basavaraju, SRV Tulimilli, SP Sadhu, ... Current medicinal chemistry 28 (39), 8203-8236, 2021 | 82 | 2021 |
The current status and challenges in the development of vaccines and drugs against Severe Acute Respiratory Syndrome‐Corona Virus‐2 (SARS‐CoV‐2) NM Beeraka, SRV Tulimilli, M Karnik, SP Sadhu, RR Pragada, G Aliev, ... BioMed research international 2021 (1), 8160860, 2021 | 28 | 2021 |
Cellular crosstalk mediated by platelet-derived growth factor BB and transforming growth factor β during hepatic injury activates hepatic stellate cells S Mekala, SRV Tulimilli, R Geesala, K Manupati, NR Dhoke, A Das Canadian journal of physiology and pharmacology 96 (8), 728-741, 2018 | 24 | 2018 |
COVID-19: diabetes perspective—pathophysiology and management S Dallavalasa, SRV Tulimilli, J Prakash, R Ramachandra, ... Pathogens 12 (2), 184, 2023 | 16 | 2023 |
Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and vaccine effectiveness SRV Tulimilli, S Dallavalasa, CG Basavaraju, V Kumar Rao, ... Vaccines 10 (10), 1751, 2022 | 15 | 2022 |
Assessment of clinical profile and treatment outcome in vaccinated and unvaccinated SARS-CoV-2 infected patients G Korishettar, P Chikkahonnaiah, SRV Tulimilli, S Dallavalasa, ... Vaccines 10 (7), 1125, 2022 | 12 | 2022 |
COVID-19 effects on geriatric population and failures of aminoquinoline therapy: Compilation of studies from EU, USA, and China; Safety and efficacy of vaccines in the … NM Beeraka, SRV Tulimilli, MV Greeshma, S Dallavalasa, Y Zhang, ... Current Medicinal Chemistry 29 (20), 3601-3621, 2022 | 4 | 2022 |
Folate targeting self-limiting hyperthermic nanoparticles for controlled photothermal therapy S George, A Srinivasan, SRV Tulimilli, SRV Madhunapantula, ... Journal of Materials Chemistry B 11 (29), 6911-6921, 2023 | 2 | 2023 |
Hydroxychloroquine (HCQ) Exhibits Better Binding to the Main Protease (Mpro) Compared to Spike Protein (S protein) of SARS-CoV-2: An In-silico Analysis DR Bandi, SRV Tulimilli, DA Kumar T, CK Chitturi, AS Bettadapura, ... Clinical Cancer Drugs 8 (2), 106-115, 2021 | | 2021 |